Frequency of zoledronic acid to prevent further bone loss in osteoporotic patients undergoing androgen deprivation therapy for prostate cancer.
Autor: | Wadhwa, Vivek K.1, Weston, Robin1, Parr, Nigel J.1 |
---|---|
Zdroj: | BJU International. Apr2010, Vol. 105 Issue 8, p1082-1088. 7p. 3 Charts, 3 Graphs. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |